Mejía-Aranguré JM, Núñez-Enríquez JC, Fajardo-Gutiérrez A, Rodríguez-Zepeda MC, Martín-Trejo JA, Duarte-Rodríguez DA, Medina-Sansón A, Flores-Lujano J, Jiménez-Hernández E, Núñez-Villegas NN, Pérez-Saldívar ML, Paredes-Aguilera R, Cárdenas-Cardós R, Flores-Chapa JD, Reyes-Zepeda NC, Flores-Villegas LV, Amador-Sánchez R, Torres-Nava JR, Bolea-Murga V, Espinosa-Elizondo RM, Peñaloza-González JG, Velázquez-Aviña MM, González-Bonilla C, Békker-Méndez VC, Jiménez-Morales S, Martínez-Morales GB, Rosas VH, Rangel-López A

Language: Spanish
References: 34
Page: 66-77
PDF size: 129.23 Kb.

ABSTRACT

Introduction: Acute myeloid leukemias represent the second most common childhood leukemia subtype. In Mexico, there are few studies on descriptive epidemiology for this disease. Aims: To report acute myeloid leukemia incidence for children less than 15 years of age in the Metropolitan Area of the Valley of Mexico for a period of five years (2010-2014) and to analyze whether there are differences in the incidence of acute myeloid leukemia by regions. Material and methods: A descriptive study was conducted in nine public hospitals in Mexico City. The crude annual average incidence rate and adjusted average annual incidence rate were calculated. Results: A total of 190 patients with diagnosis of de novo acute myeloid leukemia were analyzed. Male sex (57.2%) and acute myeloid leukemia-M3 subtype (25.3%) were more frequent. The adjusted average annual incidence rates for Mexico City and for the Metropolitan Area of the Valley of Mexico were 8.18 and 7.74 per million children under 15 years old, respectively. Conclusions: It seems that childhood acute myeloid leukemia incidence is increasing in Mexico City, which makes the identification of associated risk factors imperative.

REFERENCES

1. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11:355.

2. Jiménez-Hernández E, Dueñas-González MT, Arellano-Galindo J, et al. Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant. Biomed Res Int. 2015;2015:940278.

3. Jiménez-Hernández E, Jaimes-Reyes EZ, Arellano-Galindo J, et al. Survival of Mexican children with acute lymphoblastic leukaemia under treatment with the protocol from the Dana-Farber Cancer Institute 00-01. Biomed Res Int. 2015;2015:576950.

4. Grove CS, Vassiliou GS. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? Dis Model Mech. 2014;7:941-51.

5. Juliusson G, Lazarevic V, Hörstedt AS, Hagberg O, Höglund M; Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119: 3890-9.

6. Linet MS, Devesa SS. Descriptive epidemiology of childhood leukaemia. Br J Cancer. 1991;63:424-9.

7. Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013;60:728-33.

8. Fajardo-Gutiérrez A, Juárez-Ocaña S, González-Miranda G, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the cancer registry (a population-based study). BMC Cancer. 2007;7:68.

9. Rivera-Luna R, Shalkow-Klincovstein J, Velasco-Hidalgo L, et al. Descriptive epidemiology in Mexican children with cancer under an open national public health insurance program. BMC Cancer. 2014; 14:790.

10. Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, Rendón- Macías ME, Martínez-Garía MC. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol. 2002;39:25-31.

11. INEGI. Tabulados, Distrito Federal, 2010. (Acceso el 1 de marzo de 2016.) Disponible en: http://www3.inegi.org.mx/sistemas/tabuladosbasicos/ LeerArchivo.aspx?ct=29316&c=27302&s=est&f=1

12. INEGI. Tabulados, México, 2010. Disponible en: http://www3.inegi.org. mx/sistemas/tabuladosbasicos/default.aspx?c=27302&s=est

13. Torres-Degró A. Tasas de crecimiento poblacional (r): una mirada desde el modelo matemático lineal, geométrico y exponencial. CIDE Digital. 2011;2:142-60. (Acceso el 1 de marzo de 2016.) Disponible en: http:// soph.md.rcm.upr.edu/demo/images/CIDEdigital/vo2no1/CIDEvo2no1- Arnaldo%20Torres%20Degro-Tasa%20crecimiento%20poblacional. pdf

14. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. (Acceso el 1 de marzo de 2016.) Disponible en: http://www.who.int/healthinfo/paper31. pdf

15. Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Harnly M, Hertz A. Agricultural pesticide use and childhood cancer in California. Epidemiology. 2005;16:93-100.

16. Rull RP, Gunier R, Von Behren J, et al. Residential proximity to agricultural pesticide applications and childhood acute lymphoblastic leukemia. Environ Res. 2009;109:891-9.

17. Booth BJ, Ward MH, Turyk ME, Stayner LT. Agricultural crop density and risk of childhood cancer in the Midwestern United States: an ecologic study. Environ Health. 2015;14:82.

18. Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996;87:308-13.

19. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012;119:34-43.

20. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83-103.

21. Mejía-Aranguré JM, Bonilla M, Lorenzana R, et al. Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: population-based data. BMC Cancer. 2005;5:33.

22. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19:379-90.

23. Marcos-Gragera R, Cervantes-Amat M, Vicente ML, et al. Population- based incidence of childhood leukaemias and lymphomas in Spain (1993-2002). Eur J Cancer Prev. 2010;19:247-55.

24. Souza Melo CP, Campos CB, Dutra AP, et al. Correlation between FLT3- ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias. Leuk Res. 2015;39:131-7.

25. Ismail S, Ababneh N, Awidi A. Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia. Acta Haematol. 2007;118:183-7.

26. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.

27. Cancer Research UK. Acute myeloid leukaemia (AML) incidence statistics. Leukaemia (AML) incidence by sex and UK region. London. (Acceso el 2 de marzo de 2016.) Disponible en: http://www.cancerresearchuk. org/health-professional/cancer-statistics/statistics-bycancer- type/leukaemia-aml/incidence#ref-0

28. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.

29. Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:2099-107.

30. Linet MS, Brown LM, Mbulaiteye SM, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer. 2016; 138:1862-74.

31. Mejía-Aranguré JM. Molecular epidemiology of acute leukemia in children: causal model, interaction of three factors —susceptibility, environmental exposure and vulnerability period. Boletín Médico del Hospital Infantil de México; 2016.

32. Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009;124: 2658-70.

33. Hjalgrim LL, Westergaard T, Rostgaard K, et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol. 2003;158:724-35.

34. Mejía-Aranguré JM, Morales-Sánchez A, Fajardo-Gutiérrez A, et al. Childhood acute leukemias in Hispanic population: differences by age peak and immunophenotype. INTECH Open Access Publisher; 2011.